FDA — authorised 17 May 1976
- Marketing authorisation holder: SCHERING
- Status: approved
🇺🇸 Biphemanil in United States
FDA authorised Biphemanil on 17 May 1976
Marketing authorisation
Biphemanil in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Biphemanil approved in United States?
Yes. FDA authorised it on 17 May 1976.
Who is the marketing authorisation holder for Biphemanil in United States?
SCHERING holds the US marketing authorisation.